CURRICULUM VITAE
Sherif I. Heiba, M.D.
ACADEMIC APPOINTMENTS
3/06 till present
Associate Professor of Radiology
Mount Sinai School of Medicine
New York, NY
10/03 – 2/06
Associate Professor of Radiology
New York Medical College
New York, NY
7/99 – 9/03
Assistant Professor of Radiology
New York Medical College
New York, NY
1/95 –6/99
Assistant Professor,
Department of Nuclear Medicine
Faculty of Medicine
Kuwait University
7/93 – 12/94
Instructor, Division of Nuclear Medicine
University of Washington School of Medicine
Seattle, Washington
HOSPITAL APPOINTMENTS
3/06 till present
Attending Physician, Department of Radiology
Mount Sinai Medical Center
New York, NY
7/99 – 2/06
Assistant Director, Nuclear Medicine Division,
Department of Radiology
Saint Vincent’s Hospital and Medical Center
New York, NY
1/95 – 6/99
Consultant and Vice Chairman,
Nuclear Medicine Department
Mubarak Al-Kabeer Hospital
Kuwait City, Kuwait
1
Revised 12/2014
7/93 –12/94
7-12/1990
Assistant Director, Research Radionuclide Laboratory,
Attending Physician,
Division of Nuclear Medicine
Veterans Administration Medical Center
Seattle, Washington
Admitting Physician of Ambulatory Care. Veterans Administration
Medical Center - Tucson, Arizona.
DEPARTMENTAL RESPONSIBILITIES
3/06 till Present
Director, Nuclear Medicine Residency Program,
Department of Radiology
Mount Sinai School of Medicine
New York, NY
EDUCATION
9/71 – 1/78
Medical School, Alexandria University Faculty of Medicine
Alexandria, Egypt
POSTGRADUATE TRAINING
1991 - 1993
Fellow - Nuclear Cardiology/Nuclear Medicine. University of
Washington Medical Center - Seattle, Washington
1988 -1991
Resident - Internal Medicine. University of Arizona Health
Sciences Center - Tucson, Arizona
1986 - 1988
Resident - Nuclear Medicine. University of Miami/Jackson
Memorial Hospital - Miami, Florida
CERTIFICATIONS
2011
Recertification, American Board of Nuclear Medicine # 05746
2002
Recertification, American Board of Nuclear Medicine # 05746
2000
Diplomat, Certification Board of Nuclear Cardiology # 1708
1992
Diplomat, American Board of Nuclear Medicine # 05746
2
1991
Diplomat, American Board of Internal Medicine # 135616
1989
Federation Licensing Examination (FLEX)
1983
Education Commission for Foreign Medical Graduates (ECFMG)
Certification #335-023-8
1982
Visa Qualifying Examination (VQE)
1978
Medical Diploma (M.B., Ch.B.)
LICENSURE
2008
Pennsylvania # MD434154
1999
New York # 213637
1996
California # A060904
1991
Washington # 28517
1990
Arizona # 19320
1989
Florida # 55103
HONORS
Asa E. Seeds Award of Nuclear Medicine, Washington 1993
Chief Resident of Nuclear Medicine University of Miami/Jackson
Memorial Medical Center; July 1987 - June 1988
Graduated from Medical School in Top 10%
Graduated from High School with honors; 7th in Nation
PROFESSIONAL SOCIETIES
Society of Nuclear Medicine
American Society of Nuclear Cardiology
3
American College of Physicians
American College of Nuclear Physicians
American Medical Association
GRANTS AND CONTRACT SUPPORT
PREVIOUS GRANT AND CONTRACT SUPPORT
List Funding Source, Project
Title & Number
Role in Project
Dates
Funding Source: King
Pharmaceuticals Research and
Development, Inc
Role:
Co-Investigator
2001-2002
Study Title: Randomized,
single blinded, two-arm
crossover, dose-selection study
of MRE0470 as an adjunct to
myocardial perfusion imaging
Direct Costs
Supplemental Info
Direct Costs
Supplemental Info
Direct Costs
Supplemental Info
Direct Costs
Supplemental Info
PI:
James E. Udelson,
MD
List Funding Source, Project
Title & Number
Role in Project
Dates
Funding Source: King
Pharmaceuticals Research and
Development, Inc.
Role:
Co-Investigator
2002– 2003
PI: James E.
Udelson, MD
Study Title: Vasodilator
Induced Stress In CONcordance
with Adenosine
(VISION-301)
List Funding Source,
Project Title & Number
Role in Project
Funding Source: Bristol-Myers
Squibb Medical Imaging, Inc
Dates
Role:
Principle
Investigator
2003– 2005
Role in Project
Dates
Role: CoInvestigator
2007-2010
Study Title: Low dose
dobutamine Nitrate-Enhanced
Rest/Stress Tc-99m Sestamibi
Protocol (CG# 23019)
List Funding Source, Project
Title & Number
Funding Source: Blood and
Cancer Research Fund, New
York, NY.
PI: Lale
4
Study Title: Evaluation of
therapy response using FDG
PET/CT in patients with multiple
myeloma undergoing bone
marrow transplantation
Kostakoglu, M.D.
Mount Sinai
Medical Center
New York, NY
GCO# 08-0013
Role in Project
Dates
Funding Source: Mount Sinai
School Of Medicine.
Role: CoInvestigator
2010-2011
Study Title: A Combined
Evaluation Strategy of F-18
FDG PET/CT and ContrastEnhanced Diagnostic CT for
Lymph Nodes in the Neck
PI: Lale
Kostakoglu, M.D.
Direct Costs
Supplemental Info
Direct
Costs
Supplemental Info
Direct
Costs
Supplemental Info
Direct
Costs
Supplemental Info
List Funding Source, Project
Title & Number
Mount Sinai
Medical Center
New York, NY
GCO# 11-0189-00001-01-PD
CURRENT GRANT AND CONTRACT SUPPORT
Role in Project
Dates
Role: Principal
Investigator
Sherif Heiba, M.D.
Mount Sinai Medical
Center
New York, NY
2008-2012
Role in Project
Dates
Role: Principal
Investigator
Sherif Heiba, M.D.
Mount Sinai Medical
Center
New York, NY
2009-2012
Role in Project
Dates
Role: CoInvestigator
2012-2013
List Funding Source, Project Title &
Number
Funding Source: Mount Sinai
School Of Medicine
Study Title: An evaluation of the
utility of dual-isotope SPECT/CT for
localizing infections in the diabetic
foot
GCO# 09-0691-00001-04-PD
List Funding Source, Project Title &
Number
Funding Source: Mount Sinai
School Of Medicine
Study Title: The incremental value
of SPECT/CT Imaging to thyroid
gland/dual phase Sestamibi pinhole
imaging in the evaluation of primary
hyperparathyroidism Patients.
GCO# 09-1805-00001-04-PD
List Funding Source, Project Title &
Number
Funding Source: Surefire Medical,
Inc.
5
Study Title: Coiling the GDA vs.
Surefire During Y90 Infusion: The
COSY Trial
GCO#
PI: AARON M
FISCHMAN, M.D.
Mount Sinai Medical
Center
New York, NY
Role in Project
Dates
Role: CoInvestigator
2012-2013
List Funding Source, Project Title &
Number
Funding Source: Nordion
Study Title: Phase III Clinical Trial
Evaluating TheraSphere® in
Patients with Metastatic Colorectal
Carcinoma of the Liver who have
Failed First Line Chemotherapy
GCO# 12-1658-00001-01-PD
Study Title: A Prospective,
Multicenter Study, to Evaluate the
Efficacy and Safety of (18F)-ML-10,
a PET Imaging Radiotracer, in Early
Detection of Response of NonHematological Tumors to Concurrent
Chemoradiotherapy
Supplemental Info
Direct
Costs
Supplemental Info
Direct
Costs
Supplemental Info
Direct
Costs
Supplemental Info
PI: RANDALL F
HOLCOMBE, M.D.
Mount Sinai Medical
Center
New York, NY
Role in Project
Dates
Role: CoInvestigator
2012-2013
List Funding Source, Project Title &
Number
Funding Source: Aposense.
Direct
Costs
PI: Lale Kostakoglu,
M.D.
Mount Sinai Medical
Center
New York, NY
GCO# 10-0926-00001-03-PD
Role in Project
Dates
Funding Source: Mount Sinai
School Of Medicine.
Role: CoInvestigator
2012-2013
Study Title: PET/CT imaging for the
assessment of bio-distribution of
yttrium-90 (Y-90) in patients with
unresectable hepatic tumors who
have received intra arterial
radioembolization therapy with Y-90
microspheres
PI: JOSEF
MACHAC, M.D.
List Funding Source, Project Title &
Number
Mount Sinai Medical
Center
New York, NY
GCO# 12-0560-00001-01-PD
Role in Project
List Funding Source, Project Title &
Number
6
Dates
Funding Source: Medivation.
Study Title: PREVAIL: A
Multinational Phase 3, Randomized,
Double-Blind, Placebo-Controlled
Efficacy and Safety Study of Oral
MDV3100 in Chemotherapy-Naive
Patients with Progressive Metastatic
Prostate Cancer Who Have Failed
Androgen Deprivation Therapy
Role: CoInvestigator
2010-2012
PI: Simon J Hall,
M.D.
Mount Sinai Medical
Center
New York, NY
GCO# 10-1535-00001-02-PD
Role in Project
Dates
Funding Source: Mount Sinai
School Of Medicine.
Role: CoInvestigator
2009-2012
Study Title: 4-Dimensional CT
scanning versus conventional
Sestamibi scanning or CT scanning
for the localization of
hyperfunctioning parathyroid glands
PI: Randall P Owen,
M.D.
List Funding Source, Project Title &
Number
Direct
Costs
Supplemental Info
Mount Sinai Medical
Center
New York, NY
GCO# 10-1103-00001-02-PD
TEACHING ACTIVITIES
TEACHING
ACTIVITY/ TOPIC
LEVEL
ROLE
NUMBER OF
LEARNERS
YEARS
TAUGHT
30
NUMBER OF HOURS
PER
WEEK/MONTH/YEAR
6 hr/yr
Nuclear
Cardiology
Training of
Cardiology
Fellows
Conferences to
Radiology and
Nuclear Medicine
Residents
Nuclear
Cardiology
Course for
Medical Students
Medical Students
Nuclear Medicine
Introduction
Course
Medical Students
Surgical/Nuclear
Medicine
Seminars
nuclear
cardiology in
postgraduate
Divisions of
Nuclear Medicine
and Cardiology,
University of
Washington
Division of Nuclear
Medicine,
University of
Washington
University of
Washington
School of Medicine
Course
Kuwait University,
Faculty of Medicine
Course
Instructor
Instructor
25
5 hrs/yr
1993-1994
Instructor
40
4 hr/yr
1993-1994
Teaching/
Attending
30
6 hrs/yr
1995 – 1999
Kuwait University,
Faculty of Medicine
Course
Teaching/
Attending
30
5 hrs/yr
1996 – 1999
Kuwait University,
Faculty of Medicine
Teaching/
Attending
10
5 hrs/yr
1997 – 1999
7
1993-1994
cardiology
program
Tutorial lectures
for radiology and
nuclear medicine
residents
Case conference
For nuclear
medicine
residents
Nuclear
Cardiology
lectures for
Cardiology
fellows
General PET/CT
sessions
General Nuclear
Medicine
sessions
Grand Rounds,
Radionuclide
Investigations of
the Urinary Tract
Medical Grand
Rounds
Journal Club
Grand Rounds
Case conference
For nuclear
medicine
residents
Boards Review
for radiology
residents
Tutorial lectures
for radiology and
nuclear medicine
residents
Research
conferences
Nuclear Medicine
tutorial to
medical students
in anatomic
radiology
clerkship
Nuclear Medicine
tutorial to
medical students
in anatomic
radiology
clerkship
Nuclear Medicine
Residency
Program
Department
of Radiology,
New York Medical
College
Division of Nuclear
Medicine, New
York Medical
College
Division of
Cardiology,
New York Medical
College
Teaching/
Attending
20
6 hrs/yr
1999-2005
Teaching/
Attending
3
1 hr/mo
1999-2005
Teaching
20
4 hrs/yr
2001-2005
Division of Nuclear
Medicine
Division of Nuclear
Medicine
Attending
2
3 hr/wk
2006-2014
Attending
3
6 hr/wk
2006-2014
Department of
Urology
Teaching/
Attending
40
1 hr
2007
Department of
Medicine, Division
of Pediatric
Nephrology
Division of Nuclear
Medicine
Division of Nuclear
Medicine
Division of Nuclear
Medicine
Teaching/
Attending
7
1 hr
2007
Attending
12
4 hr/yr
2006-2014
Teaching/
Attending
Teaching/
Attending
12
2 hr/yr
2006-2014
5
1 hr/mo
2006-2012
Department
of Radiology
Teaching/
Attending
9
2 hr/yr
2006-2012
Department
of Radiology
Teaching/
Attending
18
12 hr/yr
2006-2014
Division of Nuclear
Medicine
Mount Sinai School
of Medicine Course
Teaching/
Attending
Teaching/
Attending
12
2 hr/yr
2006-2014
30
6 hrs/yr
2006-2008
Mount Sinai School
of Medicine Course
Teaching/
Attending
20
3 hrs/yr
2009-2014
Mount Sinai School
of Medicine,
Post graduate
Program
Director
4
8 hrs/wk
2006-2014
8
PUBLICATIONS
Peer Reviewed Original Articles
Heiba S, Jiang M, Rivera J, Genden E, Inabnet III W, Machac J, Kostakoglu L.
Direct comparison of neck pinhole dual tracer & dual phase sestamibi accuracies
with and without SPECT/CT for parathyroid adenoma detection and localization.
Clin Nucl Med. Revision under review. 2015.
Heiba, S, Kolker, D, Ong, L, Sharma, S, Travis, A, Teodorescu, V, Ellozy, S,
Kostakoglu, L, Savitch, I, Machac, J. Dual-isotope SPECT/CT impact on
hospitalized patients with suspected diabetic foot infection: saving limbs, lives,
and resources. Nucl Med Commun. 2013;34:877-884.
Jiang M, Fischman A, Nowakowski SF, Heiba S, Zhang Z, Knesaurek K,
Weintraub J and Machac J. Segmental perfusion differences on paired Tc-99m
macroaggregated albumin hepatic perfusion imaging and yttrium-90
bremsstrahlung imaging studies in SIR-Sphere radioembolization:
Associations with angiography. J Nucl Med Radiat Ther. 2012;3:1-5.
Jiang M, Nowakowski FS, Wang J, Heiba S, Zhang Z, Weintraub J, Kim E,
Machac J. Characterization of Extrahepatic Distribution of Tc-99m
Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium90 Microsphere Therapy. Cancer Biotherapy & Radiopharmaceuticals 2011, 26:
511-518.
Heiba SI, Kolker D, Mocherla B, Kapoor K, Jiang M, Son H, Rangaswamy B,
Kostakoglu L, Savitch I, DaCosta M, Machac M. The optimized evaluation of
diabetic foot infection by dual isotope SPECT/CT imaging protocol. J Foot Ankle
Surg 2010;49:529-36.
Knešaurek K, Machac J, Muzinic M, DaCosta M, Zhang Z, Heiba S. Quantitative
Comparison of yttrium-90 (90Y)-microspheres and Technetium-99m (99mTc)macroaggregated Albumin SPECT Images for Planning 90Y Therapy of Liver
Cancer. Tech Cancer Res Treat 2010;9:253-261.
Heiba SI, Raphael B, Castellon I, Altinyay E, Sandella N, Rosen G, Abdel-Dayem
HM. PET/CT image fusion error due to urinary bladder filling changes:
consequence and correction. Ann Nucl Med 2009;23:739-744.
Wiseman GA, Pacak K, O'Dorisio MS, Neumann DR, Waxman AD, Mankoff DA,
Heiba SI, Serafini AN, Tumeh SS, Khutoryansky N, Jacobson AF. Usefulness of
123I-MIBG scintigraphy in the evaluation of patients with known or suspected
9
primary or metastatic pheochromocytoma or paraganglioma: results from a
prospective multicenter trial. J Nucl Med 2009;50:1448-1454.
Vik TA, Pfluger T, Kadota R, Castel V, Tulchinsky M, Farto JC, Heiba S, Serafini
A, Tumeh S, Khutoryansky N, Jacobson AF. (123)I-mIBG scintigraphy in patients
with known or suspected neuroblastoma: Results from a prospective multicenter
trial. Pediatr Blood Cancer 2009;52:784-790.
Heiba SI, Yee G, Abdel-Dayem HM, Youssef I, Coppola J. Combined rest
redistribution thallium-201 SPECT and low-dose dobutamine contractility
assessment in a simple and practical new viability protocol. Ann Nucl Med.
2009;23:197-203.
Berson AM, Stein NF, Riegel AC, Destian S, Ng T, Tena LB, Mitnick RJ and
Heiba SI. Variability of gross tumor volume delineation in head-and-neck cancer
using PET/CT fusion, part II: The impact of a contouring protocol. Med Dosim.
2009;34:30-35.
Piperkova E, Raphael B, Altinyay ME, Castellon I, Libes R, Sandella N, Heiba S,
Abdel-Dayem H. Impact of PET/CT in comparison with same day contrast
enhanced CT in breast cancer management. Clin Nucl Med 2007;32:429-434.
Elgazzar AH, Loutfi I, Baqer M, Farghali M, Khadada M, Heiba S, Uza O,
Mahussein S, Al-Tailji S. Post-test probability for pulmonary embolism after
ventilation-perfusion scan assessed by nuclear medicine physicians.
Med Princ Pract 2005;14:217-220
Heiba SI, Abdel-Dayem HA, Gould R, Bernaski E, Morlote M, El-Zeftawy H and
Ambrose JA. Value of low dose dobutamine addition to routine dual isotope
gated SPECT myocardial imaging in patients with healed myocardial infarction or
abnormal wall thickening by echocardiogram. Am J Cardiol 2004;93:300-306.
Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, Bernick S, Mills C,
Wallack M, Abdel-Dayem HM. Retrospective analysis of sentinel node
localization in multicenteric palpable and non-palpable breast cancer. J Nucl Med
2003;44:7-10.
Heiba SI, Santiago J, Mirzaitehrane M, Jana S, Dede F and Abdel-Dayem HM
Transient post-ischemic stunning evaluation by gated SPECT thallium-201 stress
myocardial imaging: effect on systolic LV function. J Nucl Cardiol 2002;9:482490.
Santiago J, Heiba SI, Jana S, Mirzaitehrane M, Dede F and Abdel-Dayem HM
Transient ischemic stunning of the myocardium in stress thallium-201 gated
SPET perfusion imaging: Segmental analysis of myocardial perfusion, wall
motion and wall thickening changes. Eur J Nucl Med 2002;29:979-983.
10
El-Zeftawy H, Heiba SI, Jana S, Rosen G, Salem S, Santiago SF, and AbdelDayem HM. Role of repeated F-18 Fluorodeoxyglucose imaging in the
management of patients with bone and soft tissue sarcoma. Cancer Biotherap
Radiopharm 2001;16:37-45.
Higazzy E, Al-Saeedi F, Loutfi I, Heiba S, Kalaoui M, Al-Nakib B, et al. The
impact of brushing teeth on Carbon-14 urea breath test results. J Nucl Med
Technol 2000;28:162-164.
Heiba SI, Jacobson AF, Cerqueira MD, Shattuc S and Sharma S. The additive
values of radionuclide ventriculography and extent of myocardium at risk to
dipyridamole thallium-201 imaging for optimal risk stratification prior to vascular
surgery. Nucl Med Commun 1999;20: 887-894.
Heiba SI, Ziada G, Higazy E and Saleh M. Assessment of Tc-99m tetrofosmin lung
uptake: A modified method to avoid the contribution from high chest wall activity.
Nucl Med Commun 1998;9:859-866.
Heiba SI, Cerqueira MD and Jacobson AF and Ferreira MJ. The Value and
Correlates of Left Ventricular Cavity Assessment in Dipyridamole 201Tl SPET
Studies. Nucl Med Commun 1998;19:443-449.
Heiba SI, Hayat N J, Salman HS, Higazy E, Sayed ME, Saleh Z, Khalaf AI,
Naeem M and Bourosly S. Tc-99m MIBI myocardial SPECT: supine versus right
lateral imaging and comparison with coronary arteriography. J Nucl Med
1997;38:1510-1514.
Serafini A, Jeffers L, Reddy R, Heiba S, Schiff E. Early recognition of recurrent
hepatocellular carcinoma utilizing Gallium-67 citrate scintigraphy. J Nucl Med
1988;29:712-716.
Other Peer Reviewed Publications
Sideras PA, Patil V, Li Z, Heiba S, Lale Kostakoglou L. PET–CT of mesenteric
panniculitis: A potential confounder of lymphoma. Radiography 2015; 21:51-53.
Sideras PA, Heiba S, Machac J, Hechtman J, Vatti S. Mycobacterial
pseudotumor of the plantar fascia: how common is it? Clin Imaging. 2013;37:802805.
Gallagher EJ, Courgi R, Heiba S, Tamler R. Resolution of insulin-requiring
diabetes in a liver transplant recipient after treatment of a pheochromocytoma:
case report and review of literature. Minerva Endocrinol. 2011;36:341-345.
11
Jiang M, Gandikota N, Ames S, Heiba S. Identification of Urologic Complications
after Kidney Transplant. Am J Kidney Dis 2011;58:150-153.
Son H, Khan SM, Rahaman J, Cameron KL, Prasad-Hayes M, Chuang L,
Machac J, Heiba S and Kostakoglu L. Role of FDG PET/CT in Staging of
Recurrent Ovarian Cancer. RadioGraphics 2011;31:569–583.
Son H, Heiba S, Kostakoglu L, Machac J. Extraperitoneal urine leak after renal
transplantation: the role of radionuclide imaging and the value of accompanying
SPECT/CT - a case report. BMC Medical Imaging 2010,10:23;1-5.
Son H, Kositwattanarerk A, Hayes MP, Chuang L, Rahaman J, Heiba S, Machac
J, Zakashansky K, Kostakoglu L. PET/CT evaluation of cervical cancer: spectrum
of disease. Radiographics 2010;30:1251-68.
Cholewinski W, Castellon I, Raphael B, Heiba SI. Value of precise localization of
recurrent multiple myeloma with F-18 FDG PET/CT. Clin Nucl Med. 2009;34:1-3.
Heiba SI, Bernik S, Raphael B, Sandella N, Cholewinski W, and Klein P. PET/CT
distinctive role in breast carcinoma staging in the presence of brown fat adipose
tissue FDG uptake. Breast J 2005;11:457-461.
Katzel JA, Heiba SI. PET/CT F-18 FDG Scan Accurately Identifies Osteoporotic
Fractures in a Patient with Known Metastatic Colorectal Cancer. Clin Nucl Med
2005;30:651-654.
Youssef IM, Milardovic R, Perone RW, Heiba SI, Abdel-Dayem HM. Importance
of Tc-99m sulfur colloid liver spleen scan performed before indium-111 labeled
leukocyte imaging for localization of abdominal infection. Clin Nucl Med
2005;30:87-90.
Sood A, Youssef IM, Heiba SI, El-Zeftawy H, Axelrod D, Seigel B, Mills C, AbdelDayem HM. Alternative lymphatic pathway after previous axillary node dissection
in recurrent/primary breast cancer. Clin Nucl Med 2004;29:698-702.
Williams ST, Heiba SI, Whooley BP, Ciavarra GA and Abdel-Dayem HA.
Postchemoembolization liver abscess: Findings on hepatobiliary scintigraphy.
Clin Nucl Med 2002;27:179-182.
Dede F, Ajoedi NDY, Ansari SM, Jana S, Heiba SI and Abdel-Dayem HA.
Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F18 FDG positron emission tomography. Clin Nucl Med 2001;26:396-399.
Ansari SM, Heiba SI, Mills C, Abdel-Dayem HM. Localization of breast sentinel
node after axillary node dissection with diversion of lymphatic drainage to internal
12
mammary lymph nodes and the importance of delayed imaging. Clin Nucl Med
2001;26:647-648.
Heiba SI, Luo JQ, Sadek S, Macalental E, Cacavio A, Rosen G and AbdelDayem HA. Attenuation-correction induced artifact in F-18 FDG imaging
following total knee replacement. Clin Pos Imag 2000;3:237-239.
Buyukdereli G, Heiba S, Salem S, Santiago J, Goswami G, Jana S and AbdelDayem H. Tc-99m MAG3 scintigraphy in unusually dilated bilateral external
pelves. Clin Nucl Med 2000;25:471-472.
Goswami GS, Jana S, Santiago S, Buyukdereli G, Salem S, Heiba S and AbdelDayem HM. Discrepancy between Ga-67 citrate and F-18 FDG PET scans in
pulmonary infection. Clin Nucl Med 2000;25:490-491.
Heiba SI, Salem S, Jana S, et al: The utility of F-18 FDG imaging in the routine
evaluation of patients with Sarcoidosis: Preliminary report. Clin Nucl Med 2000;
25:327.
Salem S, Heiba S, Jana S, Santiago S and Abdel-Dayem HM. Unusual
presentation of solitary bone metastasis from breast carcinoma mimicking acute
osteomyelitis of mid-tibial shaft. Clin Nucl Med 2000;25:480-481.
Book Chapters
Sherif Heiba. Nuclear Medicine Bone Cases. In: Chun K Kim, ed. Nuclear Medicine
Volume, Cases in Radiology. London. Oxford University Press, in press.
Sherif I Heiba and Mohammad Zubaid. Basis of Cardiac Imaging: Myocardial
contractility and assessment of cardiac function. In: Elgazzar AH, ed. The Pathological
Basis of Nuclear Medicine, Third Edition. Berlin: Spinger-Verlag, 2014.
Sherif I Heiba and Mohammad Zubaid. Basis of Cardiac Imaging 1:Myocardial
contractility and assessment of cardiac function. In: Elgazzar AH, ed. The Pathological
Basis of Nuclear Medicine, Second Edition. Berlin: Spinger-Verlag, 2006.
Heiba SI and Zubaid M. Myocardial contractility and assessment of cardiac function. In:
Elgazzar AH, ed. The Pathological Basis of Nuclear Medicine. Berlin: Spinger-Verlag,
2001.
Abdel-Dayem HM, Luo J, Sadek S, Salem S, Santiago J, Jana S, El-Zeftawy H and
Heiba S. Multifunctional gamma camera coincidence imaging, current status and
13
evaluation of clinical results. In. Freeman L, ed. Nuclear Medicine Annual 2000.
Philadelphia: Lippincott Williams & Wilkins, 2000.
Heiba SI and Cerqueira MD. Evaluation of cardiac function. In: Cerqueira MD,
ed. Nuclear Cardiology. Massachusetts: Blackwell Scientific, 1994.
Abstracts
Knesaurek K, Eldib M, Bini J, Kim E, Heiba S, Fayad Z, Kostakoglu L. PET/MRI
and PET/CT imaging in liver selective internal radiation therapy with Y-90
microspheres. Which approach is better? Eur J Nucl Med Mol Imaging 2014;
41:S255.
Heiba S, Stempler L, Machac J, Kostakoglu L. The utility of dual isotope
SPECT/CT imaging in patient with infected pelvic pressure ulcer & suspected
osteomyelitis. J. Nucl Med 2014; 55:1972.
Zhang Z, Stempler L, Knesaurek K, Heiba S, Zaretsky V, Mihaila A. Assessment
of overall survival: Y-90 microspheres treatment of unresectable hepatocellular
carcinoma J. Nucl Med 2014; 55: 209.
Knesaurek K, Eldib M, Zhang Z, Bini J, Banibaker K, Rodriguez E, Kim E, Heiba
S, Fayad Z, Kostakoglu L. Comparison of PET/MRI and PET/CT studies in liver
selective internal radiation therapy with 90Y microspheres. J. Nucl Med 2014; 55:
1450.
Heiba S, Sideras P, Kostakoglu L, Savitch I, Machac J. The early distinction
between diabetic foot osteomyelitis and Charcot joint during initial phase
leukocyte (WBC)/bone scan dual isotope SPECT/CT imaging. J. Nucl. Med 2013;
54: 654.
Sosa N, Marshall R, Corcuera-Solano I, Knight-Greenfield A, Stern J, Machac J,
Heiba S, Kostakoglu L. Lymph node measurements based on low dose FDGPET/CT appear equivalent to those obtained by contrast-enhanced CT in
Hodgkin lymphoma. J. Nucl. Med 2013; 54: 1565.
Zhang Z, Fardanesh R, Machac J, Heiba S, Knesaurek K, Zaretsky V, Mihaila A,
Nowakowski S, Fischman A, Kim E. Comparison of therapeutic response using
RECIST criteria: Y-90 SIR-Spheres and TheraSphere treatment of unresectable
hepatocellular carcinoma. J. Nucl. Med 2013; 54: 224.
Heiba S, Kolker D, Sharma S, Travis A, Teodorescu V, Ellozy S, Kostakoglu L,
Savitch I, Machac J. Impact of dual isotope SPECT/CT on hospitalized patients
14
with suspected diabetic foot infection: Comparison to conventional imaging. J
Nucl Med 2012; 53:542.
Fardanesh MR, Gandikota N, Chari A, Jagannath S, Machac J, Heiba S,
Kostakoglu L. FDG PET/CT imaging characteristics in multiple myeloma patients
at staging and follow-up. J Nucl Med 2012; 53:1056.
Zhang Z, Machac J, Heiba S, Knesaurek K, Zaretsky V, Mihaila A, Weintraub J,
Nowakowski S, Kim E. Comparison study of the treatment of unresectable
hepatocellular carcinoma with Y-90 SIR-Spheres and Y-90 TheraSphere. J Nucl
Med 2012; 53:1201.
Heiba S, Kolker D, Ong L, Khan K, Teodorescu V, Ellozy S, Novruzov F,
Kostakoglu L, Savitch I, and Machac J. The beneficial influence of dual isotope
SPECT/CT use on management of patients with suspected diabetic foot
infection. J Nucl Med 2011;52:14P.
Heiba S, Jiang M, Rivera J, Son H, Genden E, Weber K, Inabnet W, Kostakoglu
L, Savitch I, Machac J. Direct comparison of neck pinhole dual tracer & dual
phase sestamibi accuracies with & without SPECT/CT for parathyroid adenoma
localization. J Nucl Med 2011;52:72P.
Jiang M, Nowakowski FS, Fischman A, Heiba S, Zhang Z, Weintraub J, Machac
J. Segmental perfusion differences on paired Tc-99m MAA hepatic perfusion
imaging and Yttrium-90 microsphere imaging: Associations with angiography.
J Nucl Med 2011;52:88P.
Gandikota N, Ng SA, Cotter R, Peti S, Heiba S, Machac J, Genden E, Som P,
Kostakoglu L. A combined evaluation strategy of FDG PET/CT and contrast
enhanced diagnostic CT (ceCT) for cervical lymph nodes. J Nucl Med
2011;52:98P.
Gandikota N, Simpson W, Peti S, Roayaie S, Heiba S, Machac J, Labow D,
Kostakoglu L. Performance of FDG-PET/CT and contrast enhanced MRI in the
evaluation of hepatic metastasis of gastrointestinal malignancies. J Nucl Med
2011;52:1822P.
Moonthungal S, Heiba S, Gandikota N, Kostakoglu L, Savitch I, Machac J.
Additive value of dual-time point SPECT/CT to routine planar octreotide scans. J
Nucl Med 2011;52:219P.
Khan S, Mendelson D, Peti S, Heiba S, Savitch I, Machac J, Kostakoglu L.
Solitary pulmonary nodules characterized by FDG-PET/CT and high resolution
chest CT. J Nucl Med 2011;52:487P.
15
Heiba S, Stock J, Khan S, Rosenberg H, Kostakoglu L, Savitch I and Machac J.
Advantage of SPECT/CT use in DMSA renal imaging for work-up of suspected
acute pyelonephritis. J Nucl Med. 2010; 51 (Supplement 2):425
Jiang M, Khan S, Genden E, Heiba S, Machac J and Kostakoglu L. Comparison
of FDG-PET/CT and contrast enhanced CT in detection of locoregional
recurrence in thyroid cancer patients. J Nucl Med. 2010; 51 (Supplement 2):463
Heiba S, Jiang M, Kostakoglu L, Savitch I and Machac J. Superiority of
SPECT/CT over SPECT & planar I-123 MIBG in workup of patients with known
or suspected pheochromocytoma. J Nucl Med. 2010; 51 (Supplement 2):1560
Khan S, Jiang M, Rahaman J, Hayes M, Machac J, Heiba S and KostakogluL.
The role of FDG PET/CT imaging in detection of recurrent ovarian cancer. J Nucl
Med. 2010; 51 (Supplement 2):1091
Zhang Z, Jiang M, Machac J, Heiba S, Lipszyc H, Zaretsky V, Knesaurek K,
Warner R, Weintraub J and Nowakowski S. Y-90 SIR-Sphere treatment of
unresectable liver cancers. J Nucl Med. 2010; 51 (Supplement 2):333
Heiba S, Rivera J, Jiang M, Genden E, Esfahane A, Weber K, Rivera M,
Kostakoglu L, Savitch I and Machac J. The optimized evaluation of primary
hyperparathyroid patients with dual tracer neck pinhole and SPECT/CT imaging.
J Nucl Med. 2010; 51 (Supplement 2):1573
Heiba S, Kolker D, Ong L, Khan S, Jiang M, Teodorescu V, Ellozy S, Kostakoglu
L, Savitch I and Machac J. The continuing management of diabetic foot infection:
Impact of follow-up with dual tracer SPECT/CT. J Nucl Med. 2010; 51
(Supplement 2):370
Jiang M, Machac J, Zhang Z, Heiba S, Knesaurek K, Stangl A and Weintraub J.
Deposition of Yttrium-90 microspheres in the gastroduodenum is associated with
early stasis/reflux and likely caused by reflux to the gastroduodenal artery. J Nucl
Med. 2010; 51 (Supplement 2):1162
Knesaurek K, Kolker D, Vatti S, Machac J, Kostakoglu L, Muzinic M, DaCosta M,
Son H, Kapoor K and Heiba S. Precise fusion of MRI and dual energy In-111
WBC/Tc-99m HDP SPECT/CT in diabetic foot using companion CT. J Nucl Med
2009; 50:1365P
Zhang Z, Machac J, Heiba S, Jiang M, Lipszyc H, Zaretsky V, Knesaurek K,
Warner R, Weintraub J, Nowakowski S, Stangl A, Schwartz M, Labow D,
Roayaie S and Sung M. Y-90 SIR-Sphere treatment of unresectable primary or
metastatic liver tumors. J Nucl Med 2009; 50:161P
16
Kapoor K, Lo Y, Mendelson D, Heiba S, Machac J and Kostakoglu L.
Combination of PET/CT and high resolution chest CT (HRCT) for characterizing
pulmonary nodules. J Nucl Med 2009; 50:1792P
Heiba S, Jiang M, Weintraub J, Nowakowski S, Stangl A, Nowakowski S, Kim E,
Knesaurek K, Zhang Z and Machac J. The effectiveness of SPECT/CT in hepatic
arterial Tc-99m MAA scan (MAAS) planning prior to hepatic Y-90 microsphere
therapy (YT). J Nucl Med 2009; 50:1663P
Kapoor K, Peti S, Simpson W, Heiba S, Machac J and Kostakoglu L. Review of
PET-CT findings in patients with suspected recurrence of pancreatic and
cholangiocarcinoma. J Nucl Med 2009; 50:1103P
Kapoor K, Kostakoglu L, Knesaurek K, Savitch I, Machac J and Heiba S.
Advances in the diagnostic imaging of pulmonary embolism (PE). J Nucl Med
2009; 50:1035P
Heiba S, Kolker D, Kapoor K, Son H, Kostakoglu L, Savitch I, DaCosta M and
Machac J. Does SPECT/CT use provide incremental value to dual isotope
imaging of diabetic foot? J Nucl Med 2009; 50:87P
Heiba S, Stock J, Khan S, Kostakoglu L, Savitch I and Machac J. Potential
usefulness of SPECT/CT in distinguishing scar from acute pyelonephritis (AP) in
renal cortical DMSA imaging: Preliminary data. J Nucl Med 2009; 50:558P
Son H, Kositwattanarerk A, Prasad-Hayes M, Heiba S, Machac J and Kostakoglu
L. PET/CT evaluation of recurrence of various gynecological malignancies in the
post-therapy setting. J Nucl Med 2009; 50:1100P
Jiang M, Machac J, Heiba S, Zhang Z, Knesaurek K, Weintraub J, Nowakowski
S, Stangl A and Kim E. Characterization of extrahepatic distribution of Tc-99m
macroaggregated albumin (MAA) on hepatic perfusion imaging studies (HPI) and
impact on Yttrium-90 (Y-90) microsphere therapy. J Nucl Med 2009; 50:214P
Son H, Kositwattanarerk A, Prasad-Hayes M, Heiba S, Machac J and Kostakoglu
L. PET/CT evaluation of cervical cancer at staging and restaging. J Nucl Med
2009; 50:1099P
Kositwattanarerk A, Son H, Genden E, Jiang M, Machac J, Heiba S, Peter Som
P and Kostakoglu L. PET/CT findings in patients with laryngeal cancer (LC) after
therapy. J Nucl Med 2009; 50:1056P
Kositwattanarerk A, Son H, Genden E, Jiang M, Machac J, Heiba S, Som P and
Kostakoglu L. PET/CT findings in patients with oropharyngeal cancer (OC) after
therapy. J Nucl Med 2009; 50:1054P
17
Moroni E, Chin C, Simpson W, Kim J, Roayaie S, Heiba S, Machac J, and
Kostakoglu L. Integrating FDG PET/CT interpretation with high dose contrast
enhanced CT increases restaging accuracy of bile duct carcinomas. J Nucl Med
2008; 49: 58P.
Rangaswamy B, Fatterpekar G, Kim J, Som P, Genden E, Machac J, Heiba S,
and Kostakoglu L. Combined interpretation of FDG-PET/CT and contrast
enhanced high dose CT increases accuracy of restaging in head and neck
cancers. J Nucl Med 2008; 49: 114P.
Heiba S, Kolker D, Mocherla B, Rangaswamy B, Kostakoglu L, and Machac J.
Can dual isotope SPECT/CT scan be a gold imaging standard for diabetic foot
evaluation? J Nucl Med 2008; 49: 134P.
Machac J, Heiba S, Zhang Z, Weintraub J, Nowakowski F, Stangl A, Schwartz
M, and Warner R. Value of planar and SPECT/CT Tc-99m MAA liver perfusion
imaging in planning of yttrium-90 Sir Sphere therapy of tumors of the liver. J Nucl
Med 2008; 49: 144P.
Serafini A, Heiba S, Tumeh S, and Jacobson A. Influence of SPECT on
interpretation of 123I-mIBG scintigraphy in patients with known or suspected
pheochromocytoma and neuroblastoma. J Nucl Med 2008; 49: 239P.
Heiba S, Son H, Kostakoglu L, and Machac J. The incremental value of pinhole
thyroid gland imaging to dual phase sestamibi pinhole & SPECT/CT imaging in
evaluating primary hyperparathyroidism patients. J Nucl Med 2008; 49: 243P.
Knesaurek K, Kolker D, Vatti S, Machac J, Muzinic M, DaCosta M, Zhang Z,
Mocherla B, and Heiba S. Accurate fusion of In-111 WBC SPECT/CT and MRI in
diabetic foot evaluations using CT/MRI correlation. J Nucl Med 2008; 49: 264P.
Machac J, Heiba S, Zhang Z, Weintraub J, Nowakowski F, Stangl A, Schwartz
M, and Warner R. Prediction of yttrium-90 Sir Sphere deposition by Tc-99m MAA
SPECT/CT liver perfusion imaging. J Nucl Med 2008; 49: 323P.
Moroni E, Chin C, Simpson W, Kim J, Machac J, Heiba S, Sung M, and
Kostakoglu L. The addition of contrast enhanced helical CT information to FDG
PET/CT data enhances tumor detection rate in metastatic colorectal cancer. J
Nucl Med 2008; 49: 346P.
Moroni E, Chin C, Simpson W, Kim J, Heiba S, Machac J, and Kostakoglu L. The
incremental value of high dose contrast enhanced CT with dual phase helical CT
to FDG PET/CT recurrent pancreatic carcinoma. J Nucl Med 2008; 49: 349P.
18
Heiba SI, Kolker D, Mocherla BR, Rangaswamy B, Kostakoglu L, Machac J.
Optimized diabetic foot evaluation by a novel dual bone scan & In-111 leukocyte
SPECT/CT imaging protocol: Preliminary data. J Nucl Med 2007;48:63P.
Heiba SI, Rangaswamy B, Kolker D, Kostakoglu L, Machac J. The diagnostic
confidence of SPECT & SPECT/CT in Indium-111 leukocyte scintigraphy. J Nucl
Med 2007;48:63P.
S. Heiba, B. R. Mocherla, L. Kostakoglu and J. Machac. The value of hybrid
SPECT/CT in the bone scan evaluation of patients with back pain. J Nucl Med
2007;48:122P
L. Kostakoglu, B. Mocherla, B. Roman, P. Som, J. Kim, J. Kao, S. Packer, J.
Machac, S. Sohn, S. Heiba and E. Genden.A different reading scale can
increase specificity of PET/CT imaging in head and neck squamous cell
carcinoma (HNSCC). J Nucl Med 2007;48:31P
L. Kostakoglu, S. Kim, E. Scigliano, P. Som, O. Keren, C. Grosskreutz, E.
Genden, J. Machac, S. Heiba and L. Isola. Characteristics of patients with false
positive FDG-PET findings after high dose therapy and autologous stem cell
transplantation (HDT/ASCT). J Nucl Med 2007;48:183P
A. C. Riegel, A. M. Berson, S. Destian, T. Ng*, L. B. Tena, R. J. Mitnick, N. Stein,
S. Heiba. Variability of Gross Tumor Volume Delineation in Head-and-neck
Cancer Using PET/CT Fusion, Part II: The Impact of a Contouring Protocol. I J
Radiation Oncology 2006;66:S660.
SI Heiba, I. Castellon, J. A. Katzel, R. Milardovic, E. Altinyay, B. Raphael, HM
Abdel-Dayem and J. Coppola. Can the additional evaluation of post ischemic
myocardial stunning amount in stress myocardial perfusion imaging further
enhance the risk assessment of coronary disease patients? J Nucl Med
2006;47:203P.
SI Heiba, B. Raphael, I. Castellon, E. Altinyay, N. Sandella, H. M. Abdel-Dayem
and G. Rosen. PET/CT fusion error due to urinary bladder filling changes: Simple
correction with a repeat section imaging. J Nucl Med 2006;47:235P.
SI Heiba, I. Castellon, J. Vecchio, P. Bukberg, V. Yen, E. Altinyay, B. Raphael,
HM Abdel-Dayem and I. Young1. Whole body scan post I-131 thyroid carcinoma
ablation therapy: Overlap of findings between early and delayed imaging. J Nucl
Med 2006;47:331P.
B. Raphael, M. E. Altinyay, I. Castellon, E. Piperkova, D. Kim, R. Libes, S. I.
Heiba and H. M. Abdel-Dayem. Clinical impact of intravenous contrast enhanced
diagnostic CT scan in patients with neoplastic disease in comparison with
PET/CT imaging. J Nucl Med 2006;47:222P
19
Heiba SI, Katzel JA, Altinyay E, Milarodovic R, Castellon I, Raphael B, AbdelDayem HA, Coppola J. Optimized risk assessment of coronary disease patients
by additional evaluation of post ischemic myocardial stunning amount in stress
perfusion imaging. J Nucl Cardiol 2005;12:S107.
Heiba SI, Castellon I, Raphael B, Altinyay E, Abdel-Dayem HA, Coppola J,
Elmquist T, and Mazzara J. The functional changes during low dose dobutamine
induced left ventricular cavity constriction in gated SPECT imaging and
correlation with thallium-201 myocardial uptake. J Nucl Cardiol 2005;12:S116.
Heiba SI, Castellon I, Vecchio J, Altinyay E, Bukberg P, Yen V, Abdel-Dayem HA
and Young I. Whole body scan post I-131 thyroid carcinoma ablation therapy:
early versus delayed imaging. J Nucl Med 2005;46:131P.
Heiba SI, Raphael B, Castellon I, Sandella N, Berson AM, Rosen G, AbdelDayem HM and Macdonald JS. PET/CT fusion error due to urinary bladder filling
changes: exaggeration by the oral contrast fluid load. J Nucl Med 2005;46:413P.
Altinyay ME, Tena LB, Finger PT, Castellon I, Raphael B, Heiba SI, AbdelDayem HM. PET/CT experience in choroidal melanoma. J Nucl Med
2005;46:47P.
Heiba SI, Yee G, Coppola J, Elmquist T, Braff R, Youssef I, Ambrose JA, AbdelDayem HM. Optimal viability evaluation by a simplified rest redistribution
thallium-201 and contractility assessment with low dose dobutamine combined
protocol. J Nucl Cardiol 2004;11:S36.
Heiba SI, Youssef I, Elmquist T, Coppola J, Klapholz M, Infantino M, Braff R,
Abdel-Dayem HM and Ambrose JA. Quantitative assessment of regional
myocardial thickening in various stress myocardial perfusion patterns. J Nucl
Med 2004;45:233P.
Heiba SI, Aiyer RK, Yee G, Coppola J, Elmquist T, Braff R, Youssef I, Ambrose
JA and Abdel-Dayem HM. Combined rest redistribution SPECT thallium-201 and
low dose dobutamine contractility assessment: a simple and effective myocardial
viability protocol. J Nucl Med 2004;45:234P.
Youssef IM, Aiyer R, Quimbo RD, Heiba S, Axelrod D, Seigel B, Bernick S, Mills
C, Abdel-Dayem HM. Incidence of non sentinel lymph node involvement in breast
cancer in the presence of micro or macro metastasis on the sentinel node. J Nucl
Med 2004;45:146P.
Youssef IM, Aiyer R, Quimbo RD, Heiba S, Axelrod D, Seigel B, Mills C, Bernick
S, Abdel-Dayem HM. Factors contributing to non-visualization of sentinel lymph
node in breast cancer lymphoscintigraphy. J Nucl Med 2004;45:357P.
20
Heiba SI, El-Zeftawy H, Ambrose JA & Abdel-Dayem HA. Combined restredistribution SPECT thallium-201 and low dose dobutamine myocardial viability
assessment in a simple new protocol. J Nucl Cardiol 2003;10:S12.
Heiba SI, Youssef I, El-Zeftawy H, Ambrose JA & Abdel-Dayem HA. Quantitative
regional myocardial thickening analysis in the different stress myocardial
perfusion patterns. J Nucl Cardiol 2003;10:S12.
Heiba SI, Bernaski EJ, Morlote M, Mirzaitehrane M, Dakhel M, Gould R,
Ambrose JA, Abdel-Dayem HM. The value of Low Dose Dobutamine addition to
routine dual isotope gated SPECT myocardial imaging: A simple and useful new
protocol. J Nucl Cardiol 2002;9:S16.
Heiba SI, Prakash AM, Dakhel M, Kaya GC, El-Zeftawy H, Ambrose JA, AbdelDayem HA. The diagnostic value of transient post-ischemic stunning in gated
SPECT myocardial perfusion. J Nucl Cardiol 2002;9:S20.
Heiba SI, Dakhel M, Kaya GC, Abdel-Dayem HA. Is transient myocardial
stunning in gated SPECT thallium-201 myocardial imaging affected by the
method of stress used or the severity of ischemia? J Nucl Cardiol 2002;9:S7.
Abdel-Dayem HM, Sadek S, Heiba S, Steinmetz N, Cho J, Cook W, Klein P. Tc99m rh-Annexin V for imaging apoptotic cells: clinical experience. World J Nucl
Med 2002;1(2):S99.
Jana S, Dakhel M, Kumar R, Heiba S, El-Zeftawy H, Axelrod D, Seigel B, Mills C,
Abdel-Dayem HM. Sentinel node localization in breast cancer: evaluation of
controversies. World J Nucl Med 2002;1(2):S116-117.
Jana S, Young I, Bukberg P, Luo JQ, Dakhel M, Heiba S, El-Zeftawy H, AbdelDayem HM. Comparison of 24 hrs total body radio-iodine retention for
hypothyroid versus Thyrogen stimulated whole body surveillance scan. World J
Nucl Med 2002;1(2):S38.
Jana S, Kumar R, Heiba S, Dakhel M, Axelrod D, Seigel B, Bernik S, Mills C,
Abdel-Dayem HM. Do we have to revise inclusion criteria for sentinel node
localization in breast cancer? Eur J Nucl Med 2002;29:S131.
El-Zeftawy H, Dakhel M, Heiba S, Caruana S, Abdel-Dayem HM. Evaluation of
F-18 FDG dual head coincidence imaging in diagnosis of recurrent head and
neck tumors. Eur J Nucl Med 2002;29:S271.
Dakhel M, Aladdin MM, El-Zeftawy H, Perone R, Heiba S, Abdel-Dayem HM.
Impact of hybrid F-18 FDG PET scan on initial staging of various types of
malignant lymphoma compared with CT scan. Eur J Nucl Med 2002;29:S272.
21
Heiba SI, Prakash AM, Dakhel M, Kaya GC, El-Zeftawy H, Ambrose JA, AbdelDayem HA. Does the recognition of transient post-ischemic stunning in gated
SPECT myocardial perfusion imaging have a diagnostic value in patients with
CAD? J Nucl Med 2002;43:96P.
Heiba SI, Bernaski EJ, Morlote M, Mirzaitehrane M, Dakhel M, Gould R,
Ambrose JA, Abdel-Dayem HM. The value of Low Dose Dobutamine addition in a
simple modification of routine dual isotope gated SPECT imaging protocol. J Nucl
Med 2002;43:94P.
Heiba SI, Dakhel M, Kaya GC, Abdel-Dayem HA. Transient myocardial stunning
in gated SPECT thallium-201 myocardial imaging: comparison between methods
of stress testing. J Nucl Med 2002;43:96P.
Jana S, Dakhel M, Heiba S, El-Zeftawy H, Axelrod D, Seigel B, Bernik S, Mills C,
Wallack M, Luo J, Abdel-Dayem HM. Is axillary dissection mandatory for patients
of breast cancer with tumor size 4 cm or more? J Nucl Med 2002;43:290P.
Jana S, Kumar R, Dakhel M, Heiba S, El-Zeftawy H, Axelrod D, Seigel B, Bernik
S, Mills C, Wallack M, Luo J, Abdel-Dayem HM. Multifocal/multicenteric breast
carcinoma: is it an absolute contraindication for sentinel node localization? J Nucl
Med 2002;43:20P.
El-Zeftaway H, LaBombardi V, Dakhel M, Heiba S, Abdel-Dayem H. Evaluation
of F-18 FDG PET imaging in diagnosis of disseminated mycobacterium avium
complex in AIDS patients. J Nucl Med 2002;43:127P.
Dakhel M, Sharabi A, Gillooley J, Correte L, Bonfils E, El-Zeftawy H, Perone R,
Heiba S, Abdel-Dayem HM. Comparison of F-18 FDG Hybrid PET and CT in
mediastinal staging of non-small cell lung cancer. J Nucl Med 2002;43:151P.
Santiago J, Jana S, Heiba SI, Mirzaitehrane M, Dede F and Abdel-Dayem HM.
Transient ischemic stunning of the myocardium in stress Tl-201 gated SPECT
myocardial imaging: Segmental analysis of myocardial perfusion, wall motion and
wall thickening changes. J Nucl Med 2001;42:94P.
Heiba SI, Mirzaitehrane M, Gould R, Dakhel M, Baskaran S, Morlote M, Bernaski
EJ, Ambrose J and Abdel-Dayem HA. Myocardial contractility evaluation with low
dose dobutamine during routine dual isotope gated SPECT pharmacological
stress studies: a simple and effective new imaging protocol. J Nucl Med
2001;42:6P.
Jana S, Dakhel M, Axelrod D, Seigel B, Baskaran S, Mills C, Heiba S, Wallack
M, Luo J, Sadek S, Abdel-Dayem HA. Does excisional biopsy of breast mass
affect the negative predictive value, accuracy or success rate of sentinel node
22
localization? J Nucl Med 2001;42:154P.
Heiba SI, Santiago J, Mirzaitehrane M, Jana S, Dede F and Abdel-Dayem HA.
Transient ischemic myocardial stunning in stress gated SPECT thallium-201
imaging: Methods of assessment and effect on systolic LV function J Nucl Cardiol
2001;8:S76.
Mirzaitehrane M, Heiba SI, Dede F, Santiago J, Jana S and Abdel-Dayem HA.
The feasibility of automated quantitative analysis of the gated SPECT thallium201 myocardial imaging in detection of post ischemic myocardial stunning. J Nucl
Cardiol 2001;8:S40.
Santiago J, Jana S, Heiba SI, Mirzaitehrane M, Dede F and Abdel-Dayem HM.
Myocardial stunning evaluation in stress thallium-201 gated SPECT myocardial
imaging: Segmental analysis of myocardial perfusion, wall motion and wall
thickening changes. J Nucl Cardiol 2001;8:S9.
S Jana, M Dakhel, D Axelrod, B Siegel, S Bhaskaran, C Mills, S Heiba, S Salem,
M Wallack, J Luo and H M Abdel-Dayem: Affect of Excisional of Breast Mass on
Negative Predictive Value, Accuracy or Success Rate of Sentinel Node
localization. Eur J Nucl Med 2001;28:1124.
Santiago J, Jana S, Salem S, Heiba S and Abdel-Dayem HM. The use of
Fluorine-18-Fluordeoxyglucose positron emission tomography (F-18 FDG PET)
in the follow-up of non-Hodgkin’s lymphoma in patients with acquired immune
deficiency syndrome (AIDS). Eur J Nucl Med 2000;27:1160.
Heiba SI, Salem S, Jana S, Santiago J and Abdel-Dayem HM. The utility of F-18
FDG imaging in the routine evaluation of patients with sarcoidosis: preliminary
report. Clin Nucl Med 2000;25:327.
Jana S, Santiago JF, Young I, Yen V, Heiba S, Salem S, Sethi Y, Luo J, Bukberg
P, Sadek S and Abdel-Dayem HM. Effect of Thyrogen administration on total
body radioiodine clearance in the work-up of thyroid cancer patients with normal
kidney and liver functions. J Nucl Med 2000;41:310P.
Jana S, Axelrod D, Siegel B, Santiago JF, Mills C, Heiba S, Salem S, Wallack K,
Sethi Y, Luo J and Abdel-Dayem HM. Correlation of sentinel node localization
using blue dye and radiocolloid methods in T1 & T2 breast cancer with
histopathological findings: Assessment of accuracy and negative predictive value
according to tumor size. J Nucl Med 2000;41:281P.
Jana S, Santiago J, Young I, Yen V, Buckberg P, Luo J, Heiba S, Salem S,
Sadek S and Abdel-Dayem HM. Comparison of I-123 total body retention in
disease free cancer thyroid patients with and without Thyrogen injection. Eur J
Nucl Med 2000;27:931.
23
Jana S, Axelrod D, Siegel B, Santiago J, Mills C, Heiba S, Wallack M, Salem S,
Sadek S, Abdel-Dayem HM. Evaluation of success rate, accuracy and negative
predictive value of sentinel node localization in breast cancer using blue dye and
radiocolloid methods with histopathological correlation. Eur J Nucl Med
2000;27:975.
Tailji S, Abdella N, Mooro M, Newman D, Mohamed A, Loutfi I, Yacoub TY, AlBunni A, Al-Za’sbi K, Heiba S, Elgazzar A. 99mTc MDP and In-111 labeled
leucocytes scintigraphy in diabetic foot: Optimal evaluation of simultaneous
acquisition. J Nucl Med 2000;41:327P.
Santiago J, Jana S, Salem S, Heiba S and Abdel-Dayem. Comparison between
F-18 FDG PET scans in patients with AIDS and non-Hodgkin’s lymphoma: A
preliminary report. Clin Nucl Med 2000;25:327.
S Jana, J F Santiago, I Young, V Yen, P Buckberg, J Luo, S Heiba, S Salem, S
Sadek and H M Abdel-Dayem: Rapid Clearance of I-123 in Cancer Thyroid
Patients following Thyrogen injections, Compared to Hypothyroid patients off
Thyroid replacement. VII Asia and Oceania Congress of Nuclear Medicine and
Biology & IV International Congress of Nuclear Oncology, Istanbul, Turkey, Oct
1-5, 2000.
S Jana, D Axelrod, B Siegel, J Santiago, C Mills, S Heiba, S Salem, M Wallack, Y Sethi,
J Luo and H M Abdel-Dayem: Histopathological Correlation of Sentinel Node
Localization using blue dye and radio colloid methods in early Breast Cancer. VII Asia
and Oceania Congress of Nuclear Medicine and Biology & IV International Congress of
Nuclear Oncology, Istanbul, Turkey, Oct 1-5, 2000.
Heiba SI, Higazy E, Elgazzar AH. Right lateral Tc-99m Sestamibi myocardial
perfusion SPECT: Diagnostic accuracy of quantitation. Eur J Nucl Med
1999;26:1045.
Heiba SI, Loutfi I, Al-Za’abi K, El-Doza B and Elgazzar AH. Effect of observer
variation in interpreting ventilation perfusion lung scan on patient management.
Eur J Nucl Med 1999;26:1206.
Higazi E, Kalaoui M, Alnakib B, Heiba S, Loutfi I, Patty S, Mohammed A,
Gopinath S, Matthew M, Hussein A, Samy M and Elgazzar A. Value of teeth
brushing before obtaining liquid C-14 urea breath test. Eur J Nucl Med
1999;26:1203.
Heiba SI, Loutfi I, Al-Za’abi K, El-Doza B and Elgazzar AH. The significance of
observer variation in ventilation/perfusion scan interpretation. J Nucl Med
1999;40:196P.
24
Heiba SI, Higazy E and Elgazzar AH. Diagnostic accuracy of quantitative
analysis in right lateral Tc-99m MIBI myocardial SPECT. J Nucl Med
1999;40:173P.
Heiba SI, Loutfi I, Al-Za’abi Z and Elgazzar AH. Interobserver variability in the
assessment of perfusion defect size: effect on lung scan interpretation. Eur J
Nucl Med 1998;25:891.
Baqer M, Muhassein S, Al-Tailji S, Khadada M, Higazi E, Heiba S and Elgazzar
AH. Role of nuclear medicine physicians in post ventilation/perfusion (V/Q) scan
probability of pulmonary embolism. Eur J Nucl Med 1998;25:1094.
Heiba SI, Ziada G, Higazy E and Saleh M. Pitfall of Tc-99m Tetrofosmin
Lung Uptake Assessment and How to Avoid it: Comparison with Thallium-201
and Tc-99m Sestamibi Myocardial SPECT Studies. Eur J Nucl Med 1997;24:971.
Heiba SI, Higazy EE, Sayed ME, Khalaf AI, Saleh Z, Naeem M, Salman HS,
Borously S and Hayat NJ. Preliminary analysis of myocardial Tc-99m sestamibi
SPECT vs. right lateral imaging: direct comparison of diagnostic accuracy with
coronary arteriography. J Nucl Med 1996;37:48P.
Higazi E, Sayed M, Heiba S, Khalaf A, Salman H, Saleh Z, Naeem M, Borously
S, Hayat N. Validation of Lateral Position Quantitative Tc-99m Sestamibi SPECT
Imaging with Coronary Arteriography. Eur J Nucl Med 1996;23:1259.
Heiba SI, Ziada G, Higazy E and Saleh M. Lung uptake in normal Tc-99m
Tetrofosmin myocardial SPECT: Subdivision and comparison with Tc-99m
sestamibi. 6th Asia and Oceania Congress of Nuclear Medicine and Biology,
Kyoto, Japan, 30 Sept. - 4 Oct. 1996.
Heiba SI, Jacobson AF, Shattuc S, Cerqueira MD. Additive value of radionuclide
ventriculography to dipyridamole thallium imaging for risk stratification prior to
vascular surgery. J Nucl Med 1993;34:74P.
Sfakianakis GN, Heiba S, Lockhart J, Lynn C, Zilleruelo G, Abitol C, Strauss J,
Politano V. Diuretic renography with early injection of furosemide: a reliable and
cost effective approach. J Nucl Med 1998;30:841.
Heiba S, Serafini A, Reddy R, Jeffers L. Role of gallium scintigraphy in the
follow-up of patients operated on for hepatocellular carcinoma. J Nucl Med 1987;
28:1792.
Ganz WI, Heiba S, Ganz S, Serafini A. Prognostic role of liver spleen scan in
AIDS patients. J Nucl Med 1987;28:1792.
25
Ganz WI, Ganz SS, Heiba S, Levina T, Serafini A. Diagnostic pattern of gallium67 lung uptake in AIDS patients. J Nucl Med 1987;28:1792.
ORAL PRESENTATIONS BY INVITATION
The early distinction between diabetic foot osteomyelitis and Charcot joint during
initial phase leukocyte (WBC)/bone scan dual isotope SPECT/CT imaging. June
8-12, 2013 Vancouver, BC, CANADA.
Impact of dual isotope SPECT/CT on hospitalized patients with suspected
diabetic foot infection: Comparison to conventional imaging. Society of Nuclear
Medicine Annual Meeting, Miami, FL, June 9-13, 2012.
The beneficial influence of dual isotope SPECT/CT use on management of
patients with suspected diabetic foot infection. Society of Nuclear Medicine
Annual Meeting, San Antonio, TX, June 4-8, 2011.
Direct comparison of neck pinhole dual tracer & dual phase sestamibi accuracies
with & without SPECT/CT for parathyroid adenoma localization. Society of
Nuclear Medicine Annual Meeting, San Antonio, TX, June 4-8, 2011.
Advantage of SPECT/CT use in DMSA renal imaging for work-up of suspected
acute pyelonephritis. Society of Nuclear Medicine Annual Meeting, Salt Lake
City, UT, June 6-9, 2010.
The continuing management of diabetic foot infection: Impact of follow-up with
dual tracer SPECT/CT. Society of Nuclear Medicine Annual Meeting, Salt Lake
City, UT, June 6-9, 2010.
Does SPECT/CT use provide incremental value to dual isotope imaging of
diabetic foot? Society of Nuclear Medicine Annual Meeting, Toronto, Ontario,
Canada, June 13-17, 2009.
Potential usefulness of SPECT/CT in distinguishing scar from acute
pyelonephritis (AP) in renal cortical DMSA imaging: Preliminary data. Society of
Nuclear Medicine Annual Meeting, New Orleans, LA, June 14-18, 2008.
Can dual isotope SPECT/CT scan be a gold imaging standard for diabetic foot
evaluation? Society of Nuclear Medicine Annual Meeting, New Orleans, LA, June
14-18, 2008.
Optimized diabetic foot evaluation by a novel dual bone scan & In-111 leukocyte
SPECT/CT imaging protocol: Preliminary data. Society of Nuclear Medicine
Annual Meeting, Washington, D.C., June 3-7, 2007.
26
The value of hybrid SPECT/CT in the bone scan evaluation of patients with back
pain. Society of Nuclear Medicine Annual Meeting, San Diego, CA, June 3-7,
2006.
PET/CT fusion error due to urinary bladder filling changes: Simple correction with
a repeat section imaging. Society of Nuclear Medicine Annual Meeting, San
Diego, CA, June 3-7, 2006.
Whole body scan post I-131 thyroid carcinoma ablation therapy: early versus
delayed imaging. Society of Nuclear Medicine Annual Meeting, Toronto, Canada,
June18-23, 2005
Incidence of non sentinel lymph node involvement in breast cancer in the
presence of micro or macro metastasis on the sentinel node. Society of Nuclear
Medicine Annual Meeting, Philadelphia, PA, June19-23, 2004
Does the recognition of transient post-ischemic stunning in gated SPECT
myocardial perfusion imaging have a diagnostic value in patients with CAD?
Society of Nuclear Medicine Annual Meeting, Los Angeles, CA, June15-19, 2002.
The value of Low Dose Dobutamine addition in a simple modification of routine
dual isotope gated SPECT imaging protocol. Society of Nuclear Medicine Annual
Meeting, Los Angeles, CA, June15-19, 2002.
Transient myocardial stunning in gated SPECT thallium-201 myocardial imaging:
comparison between methods of stress testing. Society of Nuclear Medicine
Annual Meeting, Los Angeles, CA, June15-19, 2002.
Myocardial contractility evaluation with low dose dobutamine during routine dual
isotope gated SPECT pharmacological stress studies: a simple and effective new
imaging protocol. Society of Nuclear Medicine Annual Meeting, Toronto, Ontario,
Canada, June 23-27, 2001
Transient ischemic stunning of the myocardium in stress Tl-201 gated SPECT
myocardial imaging: Segmental analysis of myocardial perfusion, wall motion and
wall thickening changes. Society of Nuclear Medicine Annual Meeting, Toronto,
Ontario, Canada, June 23-27, 2001.
Transient ischemic myocardial stunning in stress gated SPECT thallium-201
imaging: Methods of assessment and effect on systolic LV function. 5TH
International Conference of Nuclear Cardiology, Vienna, Austria, May 2-5, 2001
The feasibility of automated quantitative analysis of the gated SPECT thallium201 myocardial imaging in detection of post ischemic myocardial stunning. 5 TH
International Conference of Nuclear Cardiology, Vienna, Austria, May 2-5, 2001.
27
Inter-observer variability in the assessment of perfusion defect size: effect on
lung scans interpretation. Joint EANM and WFNM&B Congress August 30 Sept. 4, 1998, Berlin, Germany
“Tc-99m Sestamibi Myocardial SPECT Supine Vs Right Lateral Imaging: Direct
Comparison of Diagnostic Accuracy with Coronary Arteriography”. Annual
Meeting, Society of Nuclear Medicine, Denver, CO, June
3-5, 1996
“Pharmacological stress: A substitute for treadmill exercise for diagnosing
myocardial ischemia”. Current concepts in drug therapy CME course,
University of Washington School of Medicine, Seattle, WA. Nov. 4-5, 1993.
“Additive value of radionuclide ventriculography to dipyridamole thallium
imaging for risk stratification prior to vascular surgery”. Annual Meeting, Society
of Nuclear Medicine-Toronto, Canada. June 8-11, 1993.
Journal Editor
2012
International Journal of BioMed Research, India
JOURNAL REVIEWER
2014
2007-2011
2009
2005
2000
European Journal of Hematology, Germany
Journal of Urology, USA
Imaging in Medicine, USA
Lancet, UK
Journal of Nuclear Medicine, USA
CONTRIBUTION IN CD ROM (EDUCATIONAL)
Multifunctional Gamma Camera Coincidence Imaging: Current Status and
Evaluation of Clinical Results: by H Abdel-Dayem MD, J Luo PhD, S Sadek PhD,
S Salem MD, J Santiago MD, S Jana MD, Hossam El-Zeftawy MD, and S Heiba
MD. -- This CD was made to train the Nuclear Medicine Technologist and
physicians for Dual Head Coincidence Imaging.
PERSONAL DATA
Sex
Male
28
Born
January 26, 1953
Citizenship:
USA
Marital Status
Married and have 2 children
29